Evaluation of pancreas composition and function during return to normal glucose tolerance in type 2 diabetes

ISRCTN ISRCTN11969319
DOI https://doi.org/10.1186/ISRCTN11969319
Protocol serial number 10274
Sponsor Newcastle upon Tyne Hospitals NHS Foundation Trust
Funder European Foundation for the Study of Diabetes (Germany)
Submission date
21/06/2011
Registration date
21/06/2011
Last edited
21/06/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Sarah Steven
Scientific

Institute for Ageing and Health
Campus for Ageing and Vitality
Newcastle upon Tyne
NE4 5PL
United Kingdom

Study information

Primary study designInterventional
Study designRandomised interventional and observational treatment case-controlled study
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleEvaluation of pancreas composition and function during return to normal glucose tolerance in type 2 diabetes
Study acronymDRN 591
Study objectivesThe overall objective is to elucidate the pathophysiology of type 2 diabetes by defining the contribution of change in beta cell function and insulin sensitivity to the return to normal glucose homeostasis during definitive therapeutic intervention. The compelling in vitro and in vivo animal data for a direct adverse effect of fatty acid exposure on beta cell function and hepatic insulin sensitivity will be tested in vivo in people with type 2 diabetes by use of a newly devised magnetic resonance technique. The specific hypothesis will be tested that the early effect of bariatric surgery in normalising blood glucose in type 2 diabetes is brought about by the same mechanistic changes as seen during hypocaloric dieting.
Ethics approval(s)10/H0906/78
Health condition(s) or problem(s) studiedTopic: Diabetes Research Network, Metabolic and Endocrine; Subtopic: Type 2, Metabolic and Endocrine (all Subtopics); Disease: Metabolic
Intervention1. Subjects with and without type 2 diabetes will be investigated before and after gastric bypass surgery
2. Very low calorie diet (VLCD)
3. Subjects with T2DM will be randomised into 'surgery only' or 'VLCD+surgery' groups
Intervention typeMixed
Primary outcome measure(s)

First phase insulin response at baseline, 1 week after intervention and 8 weeks after surgery

Key secondary outcome measure(s)

1. Liver fat and hepatic insulin sensitivity at baseline, 1 week after intervention and 8 weeks after surgery
2. The treatment induced changes in pancreatic fat content at baseline, 1 week after intervention and 8 weeks after surgery

Completion date01/08/2012

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration28
Key inclusion criteria1. Type 2 diabetes duration less than 15 years
2. On treatment with diet alone or diet plus oral agents
3. BMI 35-45m/kg2
4. Listed for gastric bypass surgery
5. HbA1c < 10%
Key exclusion criteria1. Waist circumference >150cm
2. Kidney dysfunction (serum creatinine >150 µmol/l)
3. Liver dysfunction (serum ALT > 2.5 times the upper limit of normal)
4. Contraindications to MRI (metal implants and claustrophobia)
5. Alcohol consumption >14 units per week
6. Treatment with thiazolidinediones, insulin, GLP1 analogues or steroids
7. History of bowel surgery or inflammatory bowel disease
Date of first enrolment01/02/2011
Date of final enrolment01/08/2012

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Institute for Ageing and Health
Newcastle upon Tyne
NE4 5PL
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summary
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/01/2016 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

21/06/2016: Publication reference added.
18/12/2015: No publications found on PubMed.